Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Genitourinary 1

Conditions

Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Neoplasms 1Locally Advanced Rectal Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Advanced Solid Tumors 1

Interventions

pembrolizumab 6Proton Therapy 3spartalizumab 2Rosuvastatin Calcium 2Paclitaxel 2Immune Checkpoint Inhibitors 2Cetuximab 2toripalimab 1sotorasib 1peposertib 1osimertinib 1necitumumab 1mirdametinib 1leronlimab 1apatinib 1amivantamab 1abemaciclib 1Valganciclovir 1Trastuzumab 1Therapeutics 1Rifampin 1Radiotherapy 1PankoMab-GEX 1Panitumumab 1Midazolam 1Metformin 1MEK inhibitor I 1Jupiter 1JPT1 protein, human 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Solid Tumor, Adult × peposertib × Clear all
NCT05868174 2024-05-01

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 1 Recruiting
36 enrolled
GenitourinaryOther solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡